Search for: "Regeneron"
Results 1 - 20
of 220
Sorted by Relevance
|
Sort by Date
29 Oct 2020, 10:56 am
In Regeneron Pharmaceuticals Inc v. [read post]
27 Jul 2017, 3:16 pm
See Regeneron I, 144 F. [read post]
27 Mar 2019, 7:15 am
Regeneron Pharmaceuticals Inc. is seeking a patent attorney at the Associate Director level to assist with the development of strategies for expanding Regeneron’s intellectual property protection around key molecules, platforms and other technologies to ensure Regeneron’s long-term competitive advantage.The patent attorney will also provide IP transactional support in partnership with colleagues and clients in R&D, clinical, regulatory, legal, business and… [read post]
24 Apr 2024, 4:52 am
(Regeneron) under the False Claims Act (FCA). [read post]
1 Jul 2019, 4:15 am
Regeneron Pharmaceuticals Inc. is seeking a patent attorney at the Associate Director level to assist with the development of strategies for expanding Regeneron’s intellectual property protection around key molecules, platforms and other technologies to ensure Regeneron’s long-term competitive advantage. [read post]
25 Jun 2020, 4:37 pm
Regeneron allegedly disguised the kickbacks as charitable contributions to a foundation. [read post]
27 Jul 2017, 11:28 pm
Noonan -- In a decision that took an inordinately long time to arrive (oral argument was held in mid-January), the Federal Circuit in Regeneron Pharmaceuticals v. [read post]
31 Mar 2018, 1:23 am
In 2007, Regeneron agreed a six-year US$120 million non-exclusive licence with AstraZenca for use of the technology, under which Regeneron receives royalties on the sale of any products produced using the platform. [read post]
10 Apr 2024, 5:08 pm
(Regeneron), a New York-based pharmaceutical company. [read post]
26 Jan 2016, 4:00 am
The post Regeneron Pharmaceuticals Seeks Patent Attorney Specializing in Biologics Manufacturing appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
7 Oct 2018, 9:54 pm
Noonan -- Last week, the Supreme Court denied certiorari to Regeneron Pharmaceuticals in its appeal of the Federal Circuit's decision in Regeneron Pharmaceuticals v. [read post]
20 Apr 2022, 11:14 am
The post Regeneron Captures New Piece For Cancer With $250M Checkmate Pharma Buyout appeared first on Above the Law. [read post]
2 Jan 2018, 4:12 pm
Regeneron v. [read post]
24 Jun 2020, 6:52 am
In 2013, Regeneron sued Kymab Ltd for infringements of its patents. [read post]
7 Oct 2020, 4:15 am
(Regeneron); Pfizer, Inc. [read post]
25 Jun 2020, 9:59 am
(Regeneron), of Tarrytown, N.Y. [read post]
6 Feb 2007, 8:57 am
Singer In a February 5, 2007 press release Regeneron Pharmaceuticals, Inc. announced that it has entered into a non-exclusive license agreement with AstraZeneca involving Regeneron's VelocImmune ® antibody technology. [read post]
16 Nov 2022, 7:42 pm
Regeneron's argument was based on its assertion that the PTAB had misapplied the law regarding conception; the... [read post]
17 Jan 2017, 4:15 am
Whereas Regeneron managed... [read post]
6 Apr 2018, 8:03 am
Kymab's expert further argued that the process steps of the claim do not correspond to Regeneron's construction. [read post]
